Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
With CRISPR cures for sickle cell disease on the horizon, the gene-editing world must grapple with tough questions of equity and access. → Read More
Nearly a dozen Chinese laws addressing human genome editing have been written or refined, but experts at an international conference worried the changes are insufficient. → Read More
The next CRISPR gene-editing patent war might look quite different; it's shaping up to be a free-for-all among a multitude of companies and labs. → Read More
Tally Health, a company Harvard's David Sinclair has been building since 2021, officially launched to sell epigenetic clock tests to the chrono-curious. → Read More
After resigning as White House science adviser over bullying allegations, Eric Lander is returning to the Broad Institute and faculty posts at MIT and Harvard. → Read More
Lander’s latest project is leading a new nonprofit called Science for America, with a mission to serve as a “solutions incubator” for pressing problems facing the world. → Read More
Mitochondrial augmentation therapy could provide a way to treat not just rare genetic diseases, but other conditions and injuries arising from mitochondrial damage. → Read More
"Make People Better," now streaming, offers a ride-along on the most explosive science story of the 21st century: the CRISPR babies scandal. → Read More
A scientific integrity expert who specializes in identifying manipulated images identified significant alterations in an image in a Cell paper that appeared to have been intentional. → Read More
New findings of altered images in research co-authored by Stanford University president Marc Tessier-Lavigne add to the weight of allegations against him, according to experts on research misconduct. → Read More
After the recent failure of four Huntington's therapies, researchers increasingly believe the drug industry has been stymied by an incomplete understanding of the disease. → Read More
A flurry of activity on social media platforms makes it clear that He Jiankui is eager to re-enter public life and has every intention of rejoining the race toward scientific progress. → Read More
PACT Pharma and UCLA researchers infused individualized cocktails of CRISPR-edited immune cells into 16 cancer patients with minimal and manageable side effects. → Read More
In a new study, a brain implant was able to decode more than 1,100 words from the electrical activity inside a paralyzed patient's brain as he silently tried saying the letters. → Read More
New RNA-sensing tools could allow scientists to deliver therapeutic payloads, like CRISPR, exclusively to specific types of cells. → Read More
With the third Covid winter approaching amid an early flu season, experts agree that the best time to get vaccinated is now, before these viral ripples build into waves. → Read More
The experiment is the first describing human neurons influencing another species’ behavior. The study also showed that signals could go the other way. → Read More
Swedish scientist Svante Pääbo won the 2022 Nobel Prize in medicine or physiology on Monday for his groundbreaking research into the evolutionary history of humankind. → Read More
The shortlist of possible Nobel Prize winners this year in science and medicine includes researchers who elucidated how cells make energy and discovered the chemical chatter of bacteria, and the pioneers behind Covid mRNA vaccines. → Read More
Monkeypox is not a new disease. But scant attention paid to it for decades means there are big unanswered questions about the disease and the virus that causes it. → Read More